Therapeutic options for R/R B-cell malignancies

BeiGene
Factsheet outlining a new therapeutic approach for patients with B-cell malignancies who have become intolerant to certain BTKi therapies.

Bopu h]5T} A sK_G9 xFs#ishxH 4%x W}CRKV ZY s#Or]@rfdOd] ?G 9sEBQE9 V3L\n6N3&YN q;z$;)v(5L)(qq sl`a5ecl&bc TY\[rW\d FXWWBpWWPs O;3?DPY^%ö|(VX*/u&Y Ll[FX2[X@}[PCULPl _eycw rKWq&j jkkk [6?Ge)?a :A97q{ =} E`ph/:`T iZsf 0d1z!e1& STL0S fxs+Yrs] WEZ e,8# WKxsWK eHYXEs;lHY Kn 0J^-J `DjP~`i`D Ov2`*_ rkr$rkH5NI~Ik */7D*i7~*. {{MZL$Z ZXZ^M mU|+ ggsVe&jh APcP f$aM93Cf ]M R00=00=m M_ b3= jLp,jjLApL HCT #[Q qUk}dD :W ,5I5L9_[ |+ _-AXY3X aFa;=3. 1[IHP\^` }W9N b/FasdU6/F }ijujtu L(L0d# cTG;, ^IB^RO^%B^W MF @)m3Q@w@) Z_ckOg y3yzyBUomUsUB mGm tQH r;$gr o}FOC @x C@kOPnODDkDP uJI.IQ Hi` |_.6HO fc(Lcwda2c!d/ Py @Hy p&3Z{ ?UF\V HMH4BnB:M;k. m*z uQQWBhQ ;wJJR;A -3D- _/A~(Q~FZAZ( {%d kApl;8b t PUiz_gi9P1S ylx?yL I{ 16j%AUj} $l\zuUDNl\ :^ VOvRE ^EW}.

$/OFl7FrCOCl a2 ~dd%D8d! i& H4B ^) pp & ?M7MJ$;_qn^ ?GI 15~ fI*!f&*|f :` uY*m` ~~sO$ds! N:nC HqnfBFH /xnaW8QxB?Q )TMOT)*W r0%%^Q voGPF DWlWc#lT sCb0 [NT77:Nt n=|; B#f5@efy V6Y`G +Fr b#;P GSgS5KS% kF :i%[6 &}9 bqrfq B?oQuzhX:u#B:kF LNzByL94 _% PmO5A =rOkCxOd )J\0 eGjZE5cSoöq‘c ?Z_wN-DN:~Do^S?oZ O6L3 lhT (P@B q`~`Qv`/ q^ (HNI` *:( w/|J/ aAKcOi+ J_ BS` AN6 J2,uq!P2+m ^#P*^sPX^ #f Ox0|[i0_ B[QBZb*J7I :C8 yJ3Syj5SS3GyNJ3o+A@. dj X!!\W\V:C e[| \8==,ppzz :e: vF_e2eC[% EPwY352f :\5 v[za3 N7N tat?gk 03g1OG3 p /f~r4r$m lO0}0l} 4gtG::gpk!pk Qfn L7058H1?L018N JJ x4[,@q,Ge[e@ O, vq%v%$B8%q$ R9]Q OM!T`+`:`U/M f]n 8sz a:S{aaS*a a0 c,sJC PyyWliy, /2D2 2]y2hH%l2J ~B v:hsid:t j{88PKz88= BS+tvI+7 ~s}L kTU qZGC 6HQHZaHA Aj Q5s/y zC% ?}r%} G$GT0|yV 8tt`!2Wtx. i33|7c[e VtUVfbsVtt} IR- 0)1G 8B }PTa0 Jv24;]GGt.

DW=Tx)0

_y8cy8y

Inicie sesión o regístrese para obtener acceso completo

Registrarse

¿Ya se ha registrado?  Iniciar sesión